Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/4764
Title: Role of high sensitivity C - reactive protein (hsCRP) as a risk marker in cardio and cerebrovascular diseases and the effect of atorvastatin therapy on hsCRP
Researcher: Anand, A Vijaya
Guide(s): Kalavathy, S
Keywords: Cardiovascular disease
Stroke
C-reactive protein
Biochemistry
Upload Date: 24-Sep-2012
University: Bharathidasan University
Completed Date: n.d.
Abstract: Cardio and cerebrovascular diseases (CVDs) are multifactorial in etiology, and share some common risk factors. The death rates of these diseases are incredibly increasing due to the fact, the markers that are in existence fail to introspect the situation in detail. The Framingham Study showed that 35% of cases of coronary heart disease (CHD) were in people with normal total cholesterol (TC) levels, although the impact of elevated cholesterol on stroke risk has been disputed. These findings point out the need for markers that better predict cardiovascular risk. In the most recent years, special importance is being laid on the role of inflammation in the pathogenesis of atherosclerosis and its complications. A number of studies have examined various circulating markers of inflammations (e.g., serum amyloid A, interleukin etc.,), out of those so far studied, high-sensitivity C-reactive protein (hsCRP) seems to have the most consistent relation to the risk of CVDs in a variety of clinical settings. The objective of the present study, therefore, was to assess the prognostic value of hsCRP alone, as well as in combination with various blood lipids in patients with CVDs. The results of the present study, along with the other analyses of large population-based cohorts, confirmed the inclusion of hsCRP as a risk marker for CVDs to have important implications. The most important role of the drug statins in the reduction of serum lipids has been well documented in both primary and secondary prevention studies. However, these agents remain underutilized in several settings. More recently, evidence suggesting that statins may positively impact many organ systems and disease states independent of lipid reduction, has emerged and their anti-inflammatory properties have also been investigated. Hence, the present study was also designed to determine the effect of atorvastain on hsCRP and various other biomarkers in patients with CVDs.
Pagination: 217p.
URI: http://hdl.handle.net/10603/4764
Appears in Departments:Department of Biochemistry

Files in This Item:
File Description SizeFormat 
01_certificate.pdfAttached File84.66 kBAdobe PDFView/Open
02_declaration.pdf53.62 kBAdobe PDFView/Open
03_acknowledgements.pdf102.35 kBAdobe PDFView/Open
04_abstract.pdf51 kBAdobe PDFView/Open
05_contents.pdf143.75 kBAdobe PDFView/Open
06_list of abbreviations.pdf64.81 kBAdobe PDFView/Open
07_list of figures and plates.pdf66.02 kBAdobe PDFView/Open
08_list of tables.pdf70.99 kBAdobe PDFView/Open
09_chapter 1.pdf418.01 kBAdobe PDFView/Open
10_chapter 2.pdf966.7 kBAdobe PDFView/Open
11_chapter 3.pdf381.98 kBAdobe PDFView/Open
12_chapter 4.pdf4.96 MBAdobe PDFView/Open
13_chapter 5.pdf132.33 kBAdobe PDFView/Open
14_references.pdf1.8 MBAdobe PDFView/Open


Items in Shodhganga are protected by copyright, with all rights reserved, unless otherwise indicated.